Next-generation MRD assays: do we have the tools to evaluate them properly?

Dan Stetson, Paul Labrousse, Hugh Russell +6

Circulating tumour DNA (ctDNA) detection of molecular residual disease (MRD) in solid tumours correlates strongly with patient outcomes and is being adopted as a new clinical stand…